
The management of anemia in patients with chronic zzso failure has greatly improved with the availability of zzso human zzso in the late 1980s, leading to a considerable reduction in mortality and morbidity and to an improvement in quality of zzso The findings from recent controlled clinical outcome trials have resulted in a rather narrow, generally accepted therapeutic zzso target zzso However, currently available dosing zzso do not permit achievement and maintenance of target values within the therapeutic range in many zzso One possible explanation for this failure may be the ignorance of a finite zzso lifespan not integrated into most zzso The purpose of this article is to underline the essential role played by the zzso lifespan in the zzso response to zzso human zzso and to encourage the integration of this concept in the future development of zzso decision support zzso 

